Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Cooper

Showing results (91-100 of 324) with videos related to

Pageof 33
Sort By:
Diabetes|October 29, 2002
Altered myocellular and abdominal fat partitioning predict disturbance in insulin action in HIV protease inhibitor-related lipodystrophySeng Khee Gan, Katherine Samaras, Campbell H Thompson, et al.
HIV Clinical Trials|October 9, 2004
Progression of lipodystrophy (LD) with continued thymidine analogue usage: long-term follow-up from a randomized clinical trial (the PIILR study)Allison Martin, Don Smith, Andrew Carr, et al.
Plos One|March 5, 2013
The potential cost and benefits of raltegravir in simplified second-line therapy among HIV infected patients in Nigeria and South AfricaKaren Schneider, Chidi Nwizu, Richard Kaplan, et al.
Antiviral Therapy|October 25, 2012
Changes in metabolic, inflammatory and coagulation biomarkers after HIV seroconversion--the Health in Men (HIM) Biomarker SubstudyAmit C Achhra, Janaki Amin, Matthew G Law, et al.
AIDS (London, England)|November 21, 2007
Metabolic syndrome, cardiovascular disease and type 2 diabetes mellitus after initiation of antiretroviral therapy in HIV infectionHandan Wand, Alexandra Calmy, Dianne L Carey, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 17, 2004
The incubation period of acute retroviral syndrome as a multistep process: a parametric survival analysisPhilippe Vanhems, Nicolas Voirin, Pierre Philippe, et al.
AIDS Research and Human Retroviruses|May 31, 2002
Adaptive changes after human immunodeficiency virus type 1 transmissionVictoria A Lawson, Robert Oelrichs, Christophe Guillon, et al.
Journal of Virology|October 27, 2006
Rapid reversion of sequence polymorphisms dominates early human immunodeficiency virus type 1 evolutionBin Li, Adrianne D Gladden, Marcus Altfeld, et al.
AIDS Research and Human Retroviruses|June 22, 2010
A novel chemokine-receptor-5 (CCR5) blocker, SCH532706, has differential effects on CCR5+CD4+ and CCR5+CD8+ T cell numbers in chronic HIV infectionSarah L Pett, John Zaunders, Michelle Bailey, et al.
AIDS (London, England)|September 10, 2010
Abacavir does not affect circulating levels of inflammatory or coagulopathic biomarkers in suppressed HIV: a randomized clinical trialAllison Martin, Janaki Amin, David A Cooper, et al.
Pageof 33

Showing results (91-100 of 324) with videos related to

Sort By:
Pageof 33
Diabetes|October 29, 2002
Altered myocellular and abdominal fat partitioning predict disturbance in insulin action in HIV protease inhibitor-related lipodystrophySeng Khee Gan, Katherine Samaras, Campbell H Thompson, et al.
HIV Clinical Trials|October 9, 2004
Progression of lipodystrophy (LD) with continued thymidine analogue usage: long-term follow-up from a randomized clinical trial (the PIILR study)Allison Martin, Don Smith, Andrew Carr, et al.
Plos One|March 5, 2013
The potential cost and benefits of raltegravir in simplified second-line therapy among HIV infected patients in Nigeria and South AfricaKaren Schneider, Chidi Nwizu, Richard Kaplan, et al.
Antiviral Therapy|October 25, 2012
Changes in metabolic, inflammatory and coagulation biomarkers after HIV seroconversion--the Health in Men (HIM) Biomarker SubstudyAmit C Achhra, Janaki Amin, Matthew G Law, et al.
AIDS (London, England)|November 21, 2007
Metabolic syndrome, cardiovascular disease and type 2 diabetes mellitus after initiation of antiretroviral therapy in HIV infectionHandan Wand, Alexandra Calmy, Dianne L Carey, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 17, 2004
The incubation period of acute retroviral syndrome as a multistep process: a parametric survival analysisPhilippe Vanhems, Nicolas Voirin, Pierre Philippe, et al.
AIDS Research and Human Retroviruses|May 31, 2002
Adaptive changes after human immunodeficiency virus type 1 transmissionVictoria A Lawson, Robert Oelrichs, Christophe Guillon, et al.
Journal of Virology|October 27, 2006
Rapid reversion of sequence polymorphisms dominates early human immunodeficiency virus type 1 evolutionBin Li, Adrianne D Gladden, Marcus Altfeld, et al.
AIDS Research and Human Retroviruses|June 22, 2010
A novel chemokine-receptor-5 (CCR5) blocker, SCH532706, has differential effects on CCR5+CD4+ and CCR5+CD8+ T cell numbers in chronic HIV infectionSarah L Pett, John Zaunders, Michelle Bailey, et al.
AIDS (London, England)|September 10, 2010
Abacavir does not affect circulating levels of inflammatory or coagulopathic biomarkers in suppressed HIV: a randomized clinical trialAllison Martin, Janaki Amin, David A Cooper, et al.
Pageof 33